Paricalcitol injection

DRUG3 trials

Sponsors

Abbott, University of Split, School of Medicine

Conditions

DialysisEnd Stage Renal DiseaseSecondary HyperparathyroidismSepsis

Phase 4

Safety and Effectiveness of Zemplar Injection in Decreasing iPTH Levels in Pediatric ESRD Subjects on Hemodialysis

CompletedNCT00053547

AbbottEnd Stage Renal Disease, Secondary Hyperparathyroidism

Start: 2002-01-31Target: 28Updated: 2006-08-02

Efficacy and Safety of 6 Months Treatment With Paricalcitol Injection or Oral in Patients With Secondary Hyperparathyroidism on Dialysis

CompletedNCT00537979

AbbottDialysis, Secondary Hyperparathyroidism

Start: 2007-09-30End: 2010-07-31Updated: 2011-10-25

Unknown Phase

The Impact of Selective Vitamin D Receptor Activation on Clinical Outcomes in Septic Patients

Not yet recruitingNCT06209268

University of Split, School of MedicineSepsis

Start: 2025-05-01End: 2026-02-01Target: 90Updated: 2024-12-06